Brad Amendt, PhD
Introduction
Research in the Amendt laboratory focuses on three major areas, 1) studying the expression and regulation of transcription factor genes and signaling processes involved in craniofacial/tooth development 2) the molecular basis of selected human genetic disorders and 3) the role of stem cells and microRNAs in regulating craniofacial and regenerative medicine. My laboratory is dedicated to understanding the role of transcription factors and signaling pathways in tooth and craniofacial development. The overall goal of the laboratory is to elucidate the combinatorial code of factors and mechanisms required for normal development of teeth and craniofacial structures. These data can then be used to understand the molecular control of these developmental processes.
The planar cell polarity effector gene, Fuz, and FoxJ1 transcription factor coordinate cell polarity, ciliogenesis, Hedgehog (Hh) and Wnt signaling and gene expression during dental and craniofacial development. Fuz signaling mechanisms are both cilia dependent and cilia independent and both mechanisms regulate different signaling pathways. The Fuz null mice have massive craniofacial defects including cleft palate and tooth agenesis. FoxJ1 null mice have late stage tooth developmental anomalies affecting enamel formation. Our studies have uncovered a link between these two factors regulating both cilia and craniofacial/tooth development. We are working to understand the role of Fuz and FoxJ1 in human birth defects. Our newly identified human FUZ mutations are critical to understanding the molecular basis of FUZ in developmental anomalies.
We are currently using microRNAs (miRs) to control stem cell development and to regenerate tissues. We have begun to demonstrate a hierarchy of dental epithelial expressed transcription factors in regulating gene expression networks required for tooth morphogenesis. Dental miRs control stemness properties of the dental progenitors cells and we have identified several novel miR transcription factor targets. These targets also function in many other developmental processes. We are using miRs to program embryonic stem cells and reprogrammed dental progenitor cells.
We work on the hierarchical interactions of homeodomain, T-box, forkhead domain and Lim domain transcription factors in craniofacial/tooth development. These transcription factors interact separately or in concert together or with other factors to regulate gene expression in a temporal and spatial mechanism. The function and interaction of these factors plays a major role in the timing and development of teeth and craniofacial tissues.
I am committed and dedicated to training the next generation of scientists through mentoring both graduate students and post-doctoral fellows. My students are competitive and recruited for outstanding post-doctoral positions and post-docs have been successful in obtaining research positions. The T90 support mechanism is critical for the training of qualified students and post-docs.
Human genetic defects provide a wealth of knowledge to our understanding of gene function and in reciprocation understanding gene function allows us to better understand genetic defects. The laboratory strives to provide the basic framework for the development of technologies towards treating human genetic defects. Preparing and training graduate students for a career in research is an extremely important aspect of my career and required to advance knowledge.
Research in the Amendt laboratory is funded by grants from the NIH.
Current Positions
- Professor of Anatomy and Cell Biology
- Professor of Orthodontics
- Director, Craniofacial Anomalies Research Center
Education
- MS in Pathology and Biochemistry, University of Iowa, Iowa City, Iowa
- PhD in Microbiology and Molecular Biology, University of Iowa, Iowa City, Iowa
- BS in Botany and Chemistry, University of Iowa, Iowa City, Iowa
Graduate Program Affiliations
Center, Program and Institute Affiliations
Research Interests
- Amendt Research Areas of Interest
Selected Publications
- Epigenetic Regulation of Ameloblast Differentiation by HMGN Proteins. He B, Kram V, Furusawa T, Duverger O, Chu EY, Nanduri R, Ishikawa M, Zhang P, Amendt BA, Lee JS, Bustin M. J Dent Res. 2024 Jan;103(1):51-61. doi: 10.1177/00220345231202468.
- RNA Technology to Regenerate and Repair Alveolar Bone Defects. Su D, Swearson S, Eliason S, Rice KG, Amendt BA.J Dent Res. 2024 Jun;103(6):622-630. doi: 10.1177/00220345241242047. Epub 2024 May 7.PMID: 38715225
- Wolf-Hirschhorn syndrome candidate 1 (Whsc1) methyltransferase signals via a Pitx2-miR-23/24 axis to effect tooth development. Su D, Eliason S, Sun Z, Shao F, Amendt BA.J Biol Chem. 2023 Nov;299(11):105324. doi: 10.1016/j.jbc.2023.105324. Epub 2023 Oct 6.PMID: 37806494
- Exploring microRNAs in craniofacial regenerative medicine. Su D, Swearson S, Krongbaramee T, Sun H, Hong L, Amendt BA. Biochem Soc Trans. 2023 Apr 19 2023: 1448. doi: 10.1042/.
- Genetic Variants in Protein Tyrosine Phosphatase Non-Receptor Type 23 Are Responsible for Mesiodens Formation Ploy Adisornkanj 1,2,Rajit Chanprasit 3,Steven Eliason4,Juan M. Fons 5,Worrachet Intachai 1,Sissades Tongsima 6,Bjorn Olsen7,Stefan T. Arold 8,9,Chumpol Ngamphiw 6,Brad A. Amendt4,10,Abigail S. Tucker5 and Piranit Kantaputra1,2 Biology 2023, 12(3), 393; https://doi.org/10.3390/biology12030393
- Genetic heterogeneity and enrichment of variants in DNA-repair genes in ameloblastoma. Awotoye W, Whitt JC, Yoo B, Farooqi MS, Farrow EG, Allareddy V, Amendt BA, Rengasamy Venugopalan S.J Oral Pathol Med. 2023 Mar;52(3):263-270. doi: 10.1111/jop.13410. Epub 2023 Feb 21.PMID: 36715450
- Exploring craniofacial and dental development with microRNAs. Su D, Krongbaramee T, Sun H, Hong L, Amendt BA. Biochem Soc Trans. 2022 Dec 16;50(6):1897-1909. doi: 10.1042/BST20221042.
- Plasmid encoding miRNA-200c delivered by CaCO3-based nanoparticles enhances rat alveolar bone formation. Remy MT, Ding Q, Krongbaramee T, Hu J, Mora Mata AV, Haes AJ, Amendt BA, Sun H, Buchakjian MR, Hong L.Nanomedicine (Lond). 2022 Sep 20. doi: 10.2217/nnm-2022-0151.
- Extracellular vesicle expansion of PMIS-miR-210 expression inhibits colorectal tumour growth via apoptosis and an XIST/NME1 regulatory mechanism. Eliason S, Hong L, Sweat Y, Chalkley C, Cao H, Liu Q, Qi H, Xu H, Zhan F, Amendt BA.Clin Transl Med. 2022 Sep;12(9):e1037. doi: 10.1002/ctm2.1037.PMID: 36116139